Doccla, a pioneering “hospital at home” startup, has secured $46 million in Series B funding to fuel its European expansion. The round, led by Insight Partners, will enable Doccla to reach more patients across the continent and establish itself as a leading provider of virtual care.

Doccla’s innovative model allows patients to receive hospital-level care in the comfort of their own homes. Through a dedicated team of nurses, doctors, and technologists, the company offers a comprehensive suite of services, including remote monitoring, virtual consultations, and medication management. This approach not only provides patients with a more comfortable and personalized experience but also reduces the strain on traditional hospitals, offering cost savings and improved access to care.

The funding comes at a time when demand for virtual healthcare solutions is soaring. Doccla’s unique value proposition, coupled with the growing recognition of the benefits of “hospital at home” models, has attracted significant interest from investors. The new capital will be used to scale Doccla’s operations in existing markets like Spain and Germany, and expand into new European territories.

“This investment will allow us to accelerate our mission of bringing high-quality, convenient, and affordable healthcare to more patients across Europe,” stated [Name of CEO], CEO of Doccla. “We believe that the future of healthcare is about providing personalized and accessible care, and we are committed to making this a reality.”

Doccla’s success highlights the growing potential of virtual care models to address the challenges facing healthcare systems around the world. The company’s expansion into Europe signifies a broader shift towards patient-centered care, offering hope for a more efficient, accessible, and comfortable healthcare experience for everyone.